Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy
J Mei, X Liu, HX Tian, Y Chen, Y Cao… - Clinical and …, 2024 - Wiley Online Library
Background Organoid technology is an emerging and rapidly growing field that shows
promise in studying organ development and screening therapeutic regimens. Although …
promise in studying organ development and screening therapeutic regimens. Although …
Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy.
J Mei, X Liu, HX Tian, Y Chen, Y Cao… - Clinical & …, 2024 - search.ebscohost.com
Background: Organoid technology is an emerging and rapidly growing field that shows
promise in studying organ development and screening therapeutic regimens. Although …
promise in studying organ development and screening therapeutic regimens. Although …
[HTML][HTML] Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy
J Mei, X Liu, HX Tian, Y Chen, Y Cao… - Clinical and …, 2024 - ncbi.nlm.nih.gov
Background Organoid technology is an emerging and rapidly growing field that shows
promise in studying organ development and screening therapeutic regimens. Although …
promise in studying organ development and screening therapeutic regimens. Although …
Tumour organoids and assembloids: Patient-derived cancer avatars for immunotherapy
J Mei, X Liu, HX Tian, Y Chen, Y Cao… - Clinical and …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Organoid technology is an emerging and rapidly growing field that shows
promise in studying organ development and screening therapeutic regimens. Although …
promise in studying organ development and screening therapeutic regimens. Although …
Tumour organoids and assembloids: Patient-derived cancer avatars for immunotherapy.
J Mei, X Liu, HX Tian, Y Chen, Y Cao… - Clinical and …, 2024 - europepmc.org
Background Organoid technology is an emerging and rapidly growing field that shows
promise in studying organ development and screening therapeutic regimens. Although …
promise in studying organ development and screening therapeutic regimens. Although …
Tumour organoids and assembloids: Patient-derived cancer avatars for immunotherapy.
J Mei, X Liu, HX Tian, Y Chen, Y Cao… - Clinical and …, 2024 - europepmc.org
Background Organoid technology is an emerging and rapidly growing field that shows
promise in studying organ development and screening therapeutic regimens. Although …
promise in studying organ development and screening therapeutic regimens. Although …